Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
7.00
+0.80 (12.90%)
At close: Apr 1, 2025, 4:00 PM
6.85
-0.15 (-2.14%)
After-hours: Apr 1, 2025, 5:02 PM EDT
Apollomics Market Cap
Apollomics has a market cap or net worth of $7.72 million as of April 1, 2025. Its market cap has decreased by -85.14% in one year.
Market Cap
7.72M
Enterprise Value
-13.49M
1-Year Change
-85.14%
Ranking
Category
Stock Price
$7.00
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $7.72M, a decrease of -94.04%. That is a compound annual growth rate of -56.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 6.84M | -36.41% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |